Red Cell Special Interest Group
Malaria Research
Day: Wednesday | Time: 15:00 - 16:30
Session Coordinators:
Lesley Bruce & Vanja Crew
Speakers:
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia.
Franco Turrini, University of Turin, Italy
Presentation Unavailable
Dissecting the mechanics of erythrocyte invasion by the malaria parasite P. falciparum.
Marion Koch, Department of Life Sciences, Imperial College London
Resistance to malaria through structural variation of red blood cell invasion receptors.
Gavin Band, Wellcome Trust Centre for Human Genetics, University of Oxford
Intended Audience:
Biomedical Scientists and trainees working in hospital transfusion departments, UK Blood Services, and associated services
Research scientists involved in basic research work
Clinicians who prescribe blood components in haematology, surgery, intensive care, obstetrics and trauma settings
Transfusion practitioners
Anyone in the wider scientific community who is interested in the red cell research carried out in the UK..
Learning Objectives:
1) To learn about the consequences of inhibition of an erythrocyte tyrosine kinase with Imatinib in malaria
2) to learn about the mechanics of malarial erythrocyte invasion by P. falciparum
3) to learn how the structural variation of red blood cell invasion receptors offers resistance to malaria
Brief Description:
The third session of this year's Red Cell SIG will concentrate on the novel research in the field of malaria and will help participants to understand the invasion process and egress of the parasites, which red cell proteins are involved, and which RBC diseases are maintained in the population because they protect against malaria. To learn about the action of drugs used to inhibit parasite invasion and/or life cycle and the development of vaccines to prevent malaria infection.
Session Tags:
